Novavax applies for provisional approval to TGA

Novavax has completed it’s application to the Therapeutic Goods Administration (TGA) for provisional approval.

If successful, the COVID-19 vaccine would be the fourth approved jab in Australia, after AstraZeneca, Pfizer and Moderna.

It would also become the first protein-based vaccination…